Treatment options for small cell lung cancer - do we have more choice?
Small cell lung cancer (SCLC) is a significant health problem worldwide because of its high propensity for relapse. This review discusses existing and future therapies for the treatment of SCLC.
Puglisi
M
M
Department of Medicine, The Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK.
Dolly
S
S
Faria
A
A
Myerson
J S
JS
Popat
S
S
O'Brien
M E R
ME
D000818:Animals; D000970:Antineoplastic Agents / Q000138:chemical synthesis / Q000627:therapeutic use; D024221:Antineoplastic Protocols; D035843:Biomedical Research / Q000639:trends; D002755:Choice Behavior; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis / Q000473:pathology / Q000628:therapy*; D009367:Neoplasm Staging / Q000379:methods; D011379:Prognosis; D055752:Small Cell Lung Carcinoma / Q000175:diagnosis / Q000473:pathology / Q000628:therapy*
D000970:Antineoplastic Agents